Wafik S. El-Deiry: Targeting ITGB6 to Stimulate Potent Anti-tumor Immunity
Wafik S. El-Deiry/brown.edu

Wafik S. El-Deiry: Targeting ITGB6 to Stimulate Potent Anti-tumor Immunity

Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on LinkedIn:

“Pleased to share that our long awaited paper from eldeirylab at Legorreta Cancer Center Brown Medicine has been published:

Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma.”

Title: Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma

Authors: William MacDonald, Praveen Srinivasan, Maximilian Pinho-Schwermann, Shengliang Zhang, Vida Tajiknia, Connor Purcell, Jillian Strandberg, Alexis Lannigan, Wafik El-Deiry

Read the Full Article.

Wafik S. El-Deiry: Targeting ITGB6 to Stimulate Potent Anti-tumor Immunity

More posts featuring Wafik S. El-Deiry on OncoDaily.